Trials / Unknown
UnknownNCT04997590
Clinical Study of Umbilical Cord Blood Mononuclear Cells (UCB-MNCs) in the Treatment of Traumatic Fracture Healing
Clinical Study of Umbilical Cord Blood Mononuclear Cells (UCB-MNCs) in Promoting Traumatic Fracture Healing
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Qianfoshan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to explore the effectiveness and safety of umbilical cord blood mononuclear cells in promoting traumatic fracture healing.
Detailed description
Umbilical cord blood mononuclear cells are a type of cell group containing hematopoietic stem cells, mesenchymal stem cells, neural stem cells, endothelial cells, immune cells, etc.In this study ,umbilical cord blood mononuclear cells will be used in promoting traumatic fracture healing,and the effectiveness and safety of the treatment plan was evaluated by twelve months of follow-up after treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Umbilical cord blood mononuclear cells | injection of CB-MNCs (cell count 1×108 cells/time) was performed once every 2 week for a total of 3 times. |
| DRUG | Staphylococcal Enterotoxin C | injection of staphylococcal enterotoxin C was performed once every 2 week for a total of 3 times. |
Timeline
- Start date
- 2020-12-10
- Primary completion
- 2021-12-10
- Completion
- 2022-12-10
- First posted
- 2021-08-09
- Last updated
- 2021-08-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04997590. Inclusion in this directory is not an endorsement.